Company Profile
Beijing SL Pharmaceutical Co., Ltd., a biopharmaceutical company, research, development, and production of genetic engineering and related drugs People's Republic of China and internationally. The company's finished formulations include temozolomide.
Its portfolio also includes arsenic trioxide, lenalidomide capsules, pegylated human granulocyte-stimulating factor injection, human granulocyte-cell stimulating factor injection, recombinant human basic fibroblast growth factor for external use recombinant human basic fibroblast growth factor gel, human interleukin-11, arsenic trioxide, thymopentin, paclitaxel injection, docetaxel injection, vinorelbine tartrate injection, asparaginase, calcium folinate, gemcitabine hydrochloride, regorafenib tablets, oseltamivir phosphate capsules, ornidazole injection, adefovir dipivoxil capsules/adefovir dipivoxil tablets, ribavirin, valacyclovir hydrochloride, levofloxacin hydrochlorid, tenofovir disoproxil fumarate, cyclosporin injection/cyclosporin soft capsules, mycophenolate mofetil dispersible, coenzyme complex, enoxaparin sodium, simvastatin, telmisartan amlodipine, liposon, nitroglycerin spray, eptifibatide, argatroban, voglibose, dapagliflozin, vildagliptin, granisetron hydrochloride injection, omeprazole enteric-coated capsules, adenosylmethionine butanedisulfonate, cytidine triphosphate disodium injection cytidine triphosphate disodium injection, gabapentin, risedronate sodium, salmon calcitonin injection, lucosamine sulfate capsules, loratadine dispersible, desloratadine, naftopidil, somatostatin for injection, octreotide acetate, and etodolac sustained-release tablets.
Founded in 1994 and headquartered in Beijing, the People's Republic of China, Beijing SL Pharmaceutical was formerly known as Beijing BaiLuyuan Bio-Pharmaceutical Co., Ltd before rebranding in 1998.